Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) saw a large decline in short interest in February. As of February 27th, there was short interest totaling 1,056 shares, a decline of 90.9% from the February 12th total of 11,643 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 74,022 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 74,022 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Sonova Trading Up 3.1%

Shares of SONVY stock traded up $1.56 during mid-day trading on Tuesday, hitting $51.10. The company’s stock had a trading volume of 103,528 shares, compared to its average volume of 30,747. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. Sonova has a 52-week low of $47.55 and a 52-week high of $68.76. The business has a 50-day moving average price of $52.85 and a 200 day moving average price of $53.82.

Analyst Ratings Changes

Several brokerages recently commented on SONVY. Royal Bank Of Canada raised shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.